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 The main aim of this experiment was to compare the reactivating efficacy of newly 
developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in 
rats.  
 The reactivating activity was determinated by the standard spectrophotometric 
Ellman´s method using male Wistar laboratory rats. Our results were assessed percentage of 
reactivating of tabun–inhibited AChE or BuChE in blood, plasma, brain and diaphragm. As 
expected HI-6 was  innefective in tabun poisoning. Both of  new oximes K250 and K251 are 
less efficient than the currently available (obidoxime, trimedoxime) and so they cannot be 
recommended for the treatment.  
 
